AAortyx
Aortyx is a Barcelona-based medtech company developing a bioresorbable, biomimetic endovascular patch to treat aortic dissections, delivered via a proprietary dual-steerable catheter as a minimally invasive alternative to open surgery or stent grafts. Founded in 2018 as a spin-off from IQS School of Engineering and Hospital Clínic de Barcelona, it closed a €13.8M Series A in June 2025 to advance toward first-in-human trials.
SectorsMedical Devices, Vascular Surgery, Biomaterials
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
J
Jordi Martorell
CEO & Co-Founder
N
Noemí Balà
CTO & Co-Founder
S
Salvador Borrós
CSO & Co-Founder
V
Vicenç Riambau
CMO & Co-Founder (Head of Vascular Surgery, Hospital Clínic de Barcelona)
Global models 5
SShockwave Medical
United States · www.shockwavemedical.com ↗
VC-backed catheter-delivered device company treating vascular disease (calcified plaque via intravascular lithotripsy), later acquired by J&J for $13.1B — same model of novel minimally invasive endovascular devices replacing surgery/stents.
$450MComparable
A
Ancora Heart
United States · www.ancoraheart.com ↗
VC-funded developer of catheter-delivered structural cardiovascular repair devices, similar to Aortyx's catheter-based approach to structural vascular repair.
$260MComparable
CCathWorks
Israel / United States · cathworks.com ↗
VC-funded catheter-based vascular device/diagnostics company targeting minimally invasive alternatives to invasive vascular procedures.
$180MComparable
SSilk Road Medical
United States · www.silkroadmed.com ↗
VC-backed developer of a catheter-delivered device (TCAR) for carotid artery disease, a close analogue to Aortyx's catheter-delivered aortic patch.
$150MComparable
TTriVascular Technologies
United States · www.trivascular.com ↗
VC-funded maker of a minimally invasive aortic stent-graft system for aortic aneurysm repair, directly comparable to Aortyx's endovascular aortic device model.
$150MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
NNuubo
Madrid
Series B (estimated) · €16.3M
GGeniova
Madrid
Series A (estimated) · €16.1M
Notes: Most funded first
Investors 9
Open as list →
CClave Capital
clave.capital
GGENESIS Ventures
genesis-biomed.com
MMedex Partners
medexpartners.com
SShip2B Ventures
ship2bventures.com
CCentro para el Desarrollo Tecnológico y la Innovación
cdti.es
EEIC Fund
eic.ec.europa.eu/eic-fund_en
NNara Capital
www.nara.capital/en
E
EIT Health
eithealth.eu
V
Vergara Capital
Funding rounds 3
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-12 | Series A | €13.8M |
Ship2B Ventures, Clave Capital
+3 more
|
| 2021-05-11 | Seed (estimated) | €2.4M |
Medex Partners
+1 more
|
| 2020-03-05 | Seed | €650K | Genesis Ventures |
News 2
Open as list →| Published | Article |
|---|---|
| 2026-06-10 |
Avançsa invests €1.5 million in Aortyx to support its vascular medical technology development ↗
Capital-Riesgo.es
2026-06-10 |
| 2025-06-12 |
Aortyx secures €13.8M to bring life-saving vascular patch to humans ↗
Tech.eu
2025-06-12+1 source |